Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
about
Molecular mechanisms of peritoneal dissemination in gastric cancerCirculating tumor DNA in hepatocellular carcinoma: trends and challengesA Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma CellsComprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma.Focal Adhesion Kinase: Insight into Molecular Roles and Functions in Hepatocellular CarcinomaRelationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinomaMetastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.Hepatitis B virus mutations, expression quantitative trait loci for PTPN12, and their interactions in hepatocellular carcinoma.Clinicopathological role of miR-30a-5p in hepatocellular carcinoma tissues and prediction of its function with bioinformatics analysis.miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth.The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomyGSK-3β suppresses HCC cell dissociation in vitro by upregulating epithelial junction proteins and inhibiting Wnt/β-catenin signaling pathway.Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer.Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma.Differential Expression of Glypican-3 and Insulin–Like Growth Factor-II mRNAs and Alpha-Fetoprotein and Ki-67 Markers in HCV Related Hepatocellular Carcinomas In Egyptian PatientsA positive feedback loop of long noncoding RNA CCAT2 and FOXM1 promotes hepatocellular carcinoma growth.High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes.Gene silencing of Nox4 by CpG island methylation during hepatocarcinogenesis in rats.An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma.Gene expression, regulation of DEN and HBx induced HCC mice models and comparisons of tumor, para-tumor and normal tissues.Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins.Effect of NET-1 siRNA conjugated sub-micron bubble complex combined with low-frequency ultrasound exposure in gene transfection.ARK5 promotes invasion and migration in hepatocellular carcinoma cells by regulating epithelial-mesenchymal transition.Expression and role of VEGFA and miR-381 in portal vein tumor thrombi in patients with hepatocellular carcinoma.
P2860
Q26738538-8A2B51B1-349A-4E88-813D-CD8110E5B996Q26749417-34E44631-147E-4169-902B-483D8DC92C02Q28553513-B7730D8D-ACA3-4880-ACF3-3D2A80E8E300Q33905532-992AE9A2-1A67-4EC0-98BE-5129F2866987Q36244298-151355A2-291E-45E5-87B6-3E7B727B00E0Q37030202-EC6EFFD3-4A34-4B6E-8768-C1D74D9B5C7AQ37046429-C2BACD7F-17F3-4565-8F9F-1B0C3F4DE742Q37094958-19D29B82-9DE2-4085-94D1-3C77DA507541Q37187684-4BB343EF-E101-47B9-942C-2E399609C8B8Q37376524-4A47B461-7F77-4FA6-B866-30C661B84258Q37588076-6871488E-6C7F-49AD-985B-CB594E2159E5Q38695750-7FCDDF5A-8AED-471E-8B0A-A1678B2E621FQ39006737-8A4F29CF-613C-453B-859A-5A422BB44E7AQ40061212-453EAD18-FE0E-42F2-9F25-4B96047484CCQ40316507-75C2B8DA-7C6C-4C3F-AD50-B325A6F36DC4Q41098230-36613F7F-88B1-45B5-89F6-5AF03115D285Q41413012-D0003CA1-22AD-4C0C-AAEF-BD159B1B23A0Q42326572-DA29AE4E-7B62-4725-9FD0-D0C50DAAD571Q42378505-65FFAE76-BBA0-4658-A433-0B1314B19B9CQ47129380-A04B346C-6585-4D0B-A455-23C09F2799D8Q48008302-CA86F0C0-8510-4D4E-8665-A85A235F8955Q49273939-51915E6A-A351-40B2-98C8-388FD8BD800CQ50053815-8A86B56F-DE41-4B5F-A273-EAF03FA1A1DAQ55297156-EC859780-AC09-4A48-BF2B-E4FD4BD1EDD8
P2860
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
@ast
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
@en
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
@nl
type
label
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
@ast
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
@en
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
@nl
prefLabel
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
@ast
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
@en
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
@nl
P2093
P2860
P3181
P1476
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
@en
P2093
Hiroyuki Sugimoto
Mitsuro Kanda
Yasuhiro Kodera
P2860
P304
P3181
P356
10.3748/WJG.V21.I37.10584
P407
P577
2015-10-07T00:00:00Z